D-0660-2020 Class II Terminated
FDA drug recall D-0660-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Dec 26, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance. The recall status is terminated (terminated Oct 22, 2020). Affected quantity: 207,585 blisters.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2020
- Initiation Date
- Dec 26, 2019
- Termination Date
- Oct 22, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 207,585 blisters
Product description
Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ
Reason for recall
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Distribution pattern
Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
Code information
JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0660-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026